be_ixf;ym_202201 d_27; ct_50
Health Information Library Frequently Asked Questions LABAs for asthma — Should I stop taking them?

LABAs for asthma — Should I stop taking them?

Answer Section

In some studies, long-acting beta agonists (LABAs) have been linked to life-threatening asthma attacks. The risk appears to be greatest when a LABA is used without also using an inhaled corticosteroid. In contrast, taking a LABA with an inhaled corticosteroid is appropriate treatment for many people who have asthma. Don't stop any of your asthma medications before checking with your doctor.

LABAs are used on a regular schedule to open narrowed airways and prevent asthma attacks. But because they may increase the risk of having a life-threatening asthma attack, the Food and Drug Administration warns that LABAs should never be used without an inhaled corticosteroid for asthma. So if you're taking a LABA without an inhaled corticosteroid for asthma, check with your doctor.

LABAs include:

  • Salmeterol (Serevent Diskus)
  • Formoterol (Perforomist)

A LABA should be taken with an inhaled corticosteroid, such as:

  • Fluticasone (Flovent)
  • Budesonide (Pulmicort Flexhaler)
  • Mometasone (Asmanex)
  • Flunisolide
  • Beclomethasone (Qvar)
  • Ciclesonide (Alvesco)

If your doctor recommends a LABA and an inhaled corticosteroid for asthma, most likely you will use a single inhaler that combines both a corticosteroid and a LABA. There are four of these medications on the market:

  • Fluticasone and salmeterol (Advair Diskus, Wixela Inhub, others)
  • Budesonide and formoterol (Symbicort)
  • Mometasone and formoterol (Dulera)
  • Fluticasone and vilanterol (Breo Ellipta)

Children who need both a LABA and a corticosteroid should take them only as a combination medication, and not as separate medications.

The benefits of LABAs to keep asthma under control generally outweigh the risks — if they're used as recommended. If you have any questions about your asthma medications, talk to your doctor.

Last Updated: December 31st, 2019